Liu, Zuqiang
Ravindranathan, Roshni
Kalinski, Pawel
Guo, Z. Sheng
Bartlett, David L.
Article History
Received: 22 July 2016
Accepted: 27 January 2017
First Online: 27 March 2017
Competing interests
: D.L.B. is a shareholder of Sillajen Biotherapeutics, a company developing oncolytic viruses. The remaining authors declare no competing financial interests.